Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.
NCT02610075
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced Solid Tumours
Metastatic Solid Tumours
Ovarian Cancer
Interventions
DRUG:
AZD1775
Sponsor
AstraZeneca